Cargando…
The prognostic and predictive power of redox protein expression for anthracycline-based chemotherapy response in locally advanced breast cancer
Neoadjuvant chemotherapy has become the standard of care for locally advanced primary breast cancer. Anthracycline-based regimens have proven to be one of the most effective treatments in this setting. As certain cytotoxic antineoplastic agents, such as anthracyclines, generate reactive oxygen speci...
Autores principales: | Woolston, Caroline M, Zhang, Lei, Storr, Sarah J, Al-Attar, Ahmad, Shehata, Mohamed, Ellis, Ian O, Chan, Stephen Y, Martin, Stewart G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3410251/ https://www.ncbi.nlm.nih.gov/pubmed/22481283 http://dx.doi.org/10.1038/modpathol.2012.60 |
Ejemplares similares
-
Topoisomerase 2 alpha as a predictor of response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer
por: Shehata, M, et al.
Publicado: (2010) -
Topo2α protein expression predicts response to anthracycline combination neo-adjuvant chemotherapy in locally advanced primary breast cancer
por: Mukherjee, A, et al.
Publicado: (2010) -
Thioredoxin and related redox systems as targets in breast cancer
por: Woolston, CM, et al.
Publicado: (2010) -
Advances in anthracycline chemotherapy : epirubicin /
Publicado: (1984) -
Prognostic value of XIAP and survivin expression in locally advanced breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy
por: Pluta, Piotr, et al.
Publicado: (2019)